Please enable JavaScript.
Coggle requires JavaScript to display documents.
CR5 Pharmacology - Coggle Diagram
CR5 Pharmacology
Chemotherapy Drugs
Cytotoxic Agents
Alkylating Agents
-
-
-
causes cross-linking between strands (prevents double-stranded to be open) and formation of alkylating agents (triggers endonucleases) which prevents DNA synthesis
-
Anti-metabolites
-
Purine antagonists
-
-
HGPT enzyme converts 6MP to compounds which inhibits the new formation of ribosyl-5-phosphate, as well as conversion to adenine and guanine nucleotides and where it induces strand breaks and base mispairing.
-
Folate antagonists
Methotrexate
inhibits DHFR enzyme and depleting intracellular FH4 which prevents synthesis of thymine (pyrimidine) and purines (AG).
-
-
-
-
Cytotoxic Antibodies
Anthracyclines
-
Therapeutic Uses
breast cancer, lymphoma, solid tumors
ADR
Cardiotoxicity
because it downregulates cardiac muscle proteins like troponin,myosin,actin leading to cell death
-
-
-
-
both performed in G2 phase
while topoisomerase activity is not restricted to G2, topoisomerase II's decatenation function is especially critical in this phase.
-
-
-
Kinase Inhibitors
inhibits protein kinases which are altered in cancer cells and may be a reason for their abnormal cell growth
carcinogen lecture
-
-
-
Monoclonal Antibodies
-
bind to receptor of cancer cells and inactives growth receptors or activate immune cells to kill them
-
-
Trastuzumab (Anti-EGF)
-
binds to and inhibits the protein (HER2) which is overexpressed in breast cancer cells causing it to proliferate rapidly
T for Tits, GF for Girlfriend
-
-
-
Neurohumoral Modulation
-
ACEI and ARB
why is it used?
drugs which can decrease preload (reduce blood volume) and afterload (vasodilation) are useful for heart failure
-
-
-
-
-
-
-